Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K.
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 20 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 20 samples: 5 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin KBreast cancer research : BCR · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE289278_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1222325 and SRA study SRP563182. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 5 replicated groups read from 20 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8788251 iCas9 KPL-1 cells, sgEmpty, SETD1A
- GSM8788252 iCas9 KPL-1 cells, sgSETD1A, SETD1A
- GSM8788253 iCas9 KPL-1 cells, sgSETD1A, rescued WT
- GSM8788254 iCas9 KPL-1 cells, sgSETD1A, rescued deltaSET
- GSM8788255 iCas9 KPL-1 cells, sgEmpty, H3K4me3
- GSM8788256 iCas9 KPL-1 cells, sgSETD1A, H3K4me3
- GSM8788257 iCas9 KPL-1 cells, sgEmpty, serine2
- GSM8788258 iCas9 KPL-1 cells, sgSETD1A, serine2
- GSM8788259 iCas9 KPL-1 cells, sgEmpty, RNAP2_rep1 iCas9 KPL-1 cells, sgEm…
- GSM8788260 iCas9 KPL-1 cells, sgSETD1A, RNAP2_rep1 iCas9 KPL-1 cells, sgSE…
- GSM8788261 iCas9 KPL-1 cells, sgEmpty, RNAP2_rep2 iCas9 KPL-1 cells, sgEm…
- GSM8788262 iCas9 KPL-1 cells, sgSETD1A, RNAP2_rep2 iCas9 KPL-1 cells, sgSE…
- GSM8788263 iCas9 KPL-1 cells, sgEmpty, rep1 iCas9 KPL-1 cells, sgEm…
- GSM8788264 iCas9 KPL-1 cells, sgEmpty, rep2 iCas9 KPL-1 cells, sgEm…
- GSM8788265 iCas9 KPL-1 cells, sgEmpty, rep3 iCas9 KPL-1 cells, sgEm…
- GSM8788266 iCas9 KPL-1 cells, sgSETD1A, rep1 iCas9 KPL-1 cells, sgSE…
- GSM8788267 iCas9 KPL-1 cells, sgSETD1A, rep2 iCas9 KPL-1 cells, sgSE…
- GSM8788268 iCas9 KPL-1 cells, sgSETD1A, rep3 iCas9 KPL-1 cells, sgSE…
- GSM8788269 iCas9 KPL-1 cells, sgKMT2pool, day0 iCas9 KPL-1 cells, sgKM…
- GSM8788270 iCas9 KPL-1 cells, sgKMT2pool, day14 iCas9 KPL-1 cells, sgKM…
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE335783 A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator promoting prostate cancer proliferation. 30 samples shares non-enzymatic, proliferation
- GSE304612 Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML. [ChIP-seq] 95 samples shares activity, drives
- GSE299801 AS04 drives superior cross-protective antibody response by increased NOTCH signaling of Dendritic Cells and proliferation of memory B cells 16 samples shares proliferation, drives
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.